Literature DB >> 2573738

La Crosse virus nucleocapsid protein controls its own synthesis in mosquito cells by encapsidating its mRNA.

D Hacker1, R Raju, D Kolakofsky.   

Abstract

Within 24 to 48 h of La Crosse virus infection of mosquito cells, greater than 75% of the S mRNA was found to band in CsCl density gradients at the position of genome or antigenome nucleocapsids. The encapsidation of the S mRNA correlates with the repression of N protein synthesis in vivo, and the encapsidated S mRNA cannot be translated in vitro. Unlike genome and antigenome assembly, S mRNA assembly is a relatively slow process, which is not coupled to its synthesis. Within the encapsidated S mRNA population, three forms could be distinguished, those with intact primers which were or were not also assembled with N protein and those in which the primer and up to 3 template bases had been lost. We suggest that genome replication, but not transcription, is down regulated with time in mosquito cells for reasons that are unclear. The pool of unassembled N protein then increased to the point at which it began to interact with its own mRNA, as this mRNA also contains what is considered to be the assembly site, i.e., the conserved sequences at the 5' ends of all genome and antigenome chains. This lead to the assembly of the entire mRNA, except for the nontemplate primer. Some of the primers were then also assembled with N protein, whereas others were digested to produce truncated mRNAs.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2573738      PMCID: PMC251180          DOI: 10.1128/JVI.63.12.5166-5174.1989

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  Binding of a cytosolic protein to the iron-responsive element of human ferritin messenger RNA.

Authors:  T A Rouault; M W Hentze; S W Caughman; J B Harford; R D Klausner
Journal:  Science       Date:  1988-09-02       Impact factor: 47.728

Review 2.  Bunyaviridae: recent biochemical developments.

Authors:  J F Obijeski; F A Murphy
Journal:  J Gen Virol       Date:  1977-10       Impact factor: 3.891

3.  Regulation of the synthesis of bacteriophage T4 gene 32 protein.

Authors:  H M Krisch; A Bolle; R H Epstein
Journal:  J Mol Biol       Date:  1974-09-05       Impact factor: 5.469

4.  LaCrosse virus gene expression in mammalian and mosquito cells.

Authors:  C Rossier; R Raju; D Kolakofsky
Journal:  Virology       Date:  1988-08       Impact factor: 3.616

5.  Translational, autogenous regulation of gene 32 expression during bacteriophage T4 infection.

Authors:  M Russel; L Gold; H Morrissett; P Z O'Farrell
Journal:  J Biol Chem       Date:  1976-11-25       Impact factor: 5.157

6.  N protein of vesicular stomatitis virus selectively encapsidates leader RNA in vitro.

Authors:  B M Blumberg; C Giorgi; D Kolakofsky
Journal:  Cell       Date:  1983-02       Impact factor: 41.582

7.  Nucleotide sequences involved in bacteriophage T4 gene 32 translational self-regulation.

Authors:  H M Krisch; B Allet
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

8.  Bunyamwera virus replication in cultured Aedes albopictus (mosquito) cells: establishment of a persistent viral infection.

Authors:  S E Newton; N J Short; L Dalgarno
Journal:  J Virol       Date:  1981-06       Impact factor: 5.103

9.  Isolation of a Singh's Aedes albopictus cell clone sensitive to Dengue and Chikungunya viruses.

Authors:  A Igarashi
Journal:  J Gen Virol       Date:  1978-09       Impact factor: 3.891

10.  Molecular cloning and sequencing of the La Crosse virus S RNA.

Authors:  C D Cabradilla; B P Holloway; J F Obijeski
Journal:  Virology       Date:  1983-07-30       Impact factor: 3.616

View more
  15 in total

1.  RNA binding properties of bunyamwera virus nucleocapsid protein and selective binding to an element in the 5' terminus of the negative-sense S segment.

Authors:  J C Osborne; R M Elliott
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Regions of importance for interaction of puumala virus nucleocapsid subunits.

Authors:  Lena Lindgren; Marie Lindkvist; Anna Overby; Clas Ahlm; Göran Bucht; Anna Holmström
Journal:  Virus Genes       Date:  2006-10       Impact factor: 2.332

3.  Anti-mRNAs in La Crosse bunyavirus-infected cells.

Authors:  D Hacker; S Rochat; D Kolakofsky
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

4.  Inhibition of Rift Valley fever virus replication and perturbation of nucleocapsid-RNA interactions by suramin.

Authors:  Mary Ellenbecker; Jean-Marc Lanchy; J Stephen Lodmell
Journal:  Antimicrob Agents Chemother       Date:  2014-09-29       Impact factor: 5.191

5.  Antivirally active MxA protein sequesters La Crosse virus nucleocapsid protein into perinuclear complexes.

Authors:  Georg Kochs; Christian Janzen; Heinz Hohenberg; Otto Haller
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-05       Impact factor: 11.205

6.  The L protein of Rift Valley fever virus can rescue viral ribonucleoproteins and transcribe synthetic genome-like RNA molecules.

Authors:  N Lopez; R Muller; C Prehaud; M Bouloy
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

7.  Characterization of Bunyamwera virus S RNA that is transcribed and replicated by the L protein expressed from recombinant vaccinia virus.

Authors:  H Jin; R M Elliott
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

8.  A novel mechanism for the initiation of Tacaribe arenavirus genome replication.

Authors:  D Garcin; D Kolakofsky
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

9.  cis-Acting signals in encapsidation of Hantaan virus S-segment viral genomic RNA by its N protein.

Authors:  W E Severson; X Xu; C B Jonsson
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

10.  Analysis of LaCrosse virus S mRNA 5' termini in infected mosquito cells and Aedes triseriatus mosquitoes.

Authors:  D K Dobie; C D Blair; L J Chandler; A Rayms-Keller; M M McGaw; L P Wasieloski; B J Beaty
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.